← ANALYST RATINGS · TIPRANKS

Claritev (CTEV): analyst forecast and price target

$22.12 −7.29% close 16.10.26 · market cap $404M · Healthcare · Medical - Healthcare Information Services IWM 0.01%
Price targets and ratings of

Analyst consensus

Strong Buy

5 Buy1 Hold0 Sell

Ratings of 6 analysts in the last 3 months

12-month forecast

$45.83+107.2% upside

Based on 6 price targets given in the last 3 months, the average target is $45.83, the highest $73.00, the lowest $30.00. The average is +107.2% from the last price of $22.12.

$20.00$40.00$60.00Jan 26AprJulOctJan 27AprJulOctHigh$73.00Average$45.83Low$30.00
Highest target $73.00 Average target $45.83 Lowest target $30.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% Barclays $40.00 Buy +80.8% Reiterated 13.10.26on TipRanks 04:50 −2.5%next day +2.0%
Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% Piper Sandler $73.00 Buy +230.0% Assigned 18.08.26on TipRanks 07:15 +1.4%next day −0.8% · 5 days +5.9%
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $22.00 → $30.00+36.4% Hold +35.6% Reiterated 12.08.26on TipRanks Aug 11 15:55 +2.9%next day +0.8% · 5 days +2.2%
Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% Canaccord Genuity $37.00 → $43.00+16.2% Buy +94.4% Assigned 10.08.26on TipRanks 07:20 +4.6%next day +2.9% · 5 days +3.8%
Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% Citi $40.00 → $45.00+12.5% Buy +103.4% Reiterated 10.08.26on TipRanks 06:45 +4.6%next day +2.9% · 5 days +3.8%
Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% Guggenheim $38.00 → $44.00+15.8% Buy +98.9% Reiterated 07.08.26on TipRanks Aug 10 07:35 +20.8%next day +4.6% · 5 days +16.6%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Claritev

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Daniel Grosslight★★★★★★★★★★Citi · #4007
Hits 47%108 of 228 Average return +3.6%
1 year Daniel Grosslight★★★★★★★★★★Citi · #4007
Hits 47%108 of 228 Average return +3.6%
2 years Daniel Grosslight★★★★★★★★★★Citi · #4007
Hits 47%108 of 228 Average return +3.6%

Most profitable

3 months Daniel Grosslight★★★★★★★★★★Citi · #4007
Hits 47%108 of 228 Average return +3.6%
1 year Daniel Grosslight★★★★★★★★★★Citi · #4007
Hits 47%108 of 228 Average return +3.6%
2 years Daniel Grosslight★★★★★★★★★★Citi · #4007
Hits 47%108 of 228 Average return +3.6%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $45.83 at a price of $21.17 (+116.5%); now: $45.83 at $22.12 (+107.2%).

$20.00$30.00$40.00Sep 15Oct 1Oct 15Top analysts$42.33Average target$45.83Price$22.12

PriceAverage targetTop analysts’ target

Recommendation trend

05102Oct 2522Nov22Dec311Jan 26212Feb313Mar222Apr341May35Jun45Jul371Aug261Sep251Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy334322
Buy455765
Hold100111
Sell000000

Earnings and sales forecast

Next report: 09.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $-3.63 (from $-3.68 to $-3.58). Last quarter: $-3.49.

Sales

Next quarter’s sales estimate — $256M (from $254M to $257M). Last quarter: $257M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Claritev
  • CEO: Travis S. Dalton
  • Employees: 3,000
  • 7900 Tysons One Place, McLean, VA, 22102, US
  • www.claritev.com

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Data from the stock’s TipRanks forecast page, read 105 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗